As of 2025-07-17, the Relative Valuation of Krystal Biotech Inc (KRYS) is 100.88 USD. This relative valuation is based on P/E multiples. With the latest stock price at 150.08 USD, the upside of Krystal Biotech Inc based on Relative Valuation is -32.8%.
The range of the Relative Valuation is 65.60 - 129.79 USD.
| Range | Selected | |
| Trailing P/E multiples | 21.5x - 30.3x | 27.1x |
| Forward P/E multiples | 25.2x - 42.7x | 32.8x |
| Fair Price | 65.60 - 129.79 | 100.88 |
| Upside | -56.3% - -13.5% | -32.8% |
| Date | P/E |
| 2025-07-17 | 35.03 |
| 2025-07-16 | 34.99 |
| 2025-07-15 | 34.44 |
| 2025-07-14 | 35.07 |
| 2025-07-11 | 34.54 |
| 2025-07-10 | 34.91 |
| 2025-07-09 | 34.71 |
| 2025-07-08 | 33.42 |
| 2025-07-07 | 32.58 |
| 2025-07-03 | 33.36 |
| 2025-07-02 | 32.95 |
| 2025-07-01 | 32.41 |
| 2025-06-30 | 32.05 |
| 2025-06-27 | 32.38 |
| 2025-06-26 | 33.24 |
| 2025-06-25 | 33.22 |
| 2025-06-24 | 33.50 |
| 2025-06-23 | 32.15 |
| 2025-06-20 | 30.88 |
| 2025-06-18 | 30.80 |
| 2025-06-17 | 30.31 |
| 2025-06-16 | 31.02 |
| 2025-06-13 | 31.96 |
| 2025-06-12 | 32.72 |
| 2025-06-11 | 32.55 |
| 2025-06-10 | 32.22 |
| 2025-06-09 | 31.73 |
| 2025-06-06 | 31.93 |
| 2025-06-05 | 30.92 |
| 2025-06-04 | 30.78 |
| 2025-06-03 | 30.52 |
| 2025-06-02 | 29.23 |
| 2025-05-30 | 29.37 |
| 2025-05-29 | 29.28 |
| 2025-05-28 | 28.76 |
| 2025-05-27 | 29.48 |
| 2025-05-23 | 29.15 |
| 2025-05-22 | 29.21 |
| 2025-05-21 | 29.53 |
| 2025-05-20 | 30.67 |
| 2025-05-19 | 30.84 |
| 2025-05-16 | 30.45 |
| 2025-05-15 | 30.39 |
| 2025-05-14 | 30.63 |
| 2025-05-13 | 31.36 |
| 2025-05-12 | 32.51 |
| 2025-05-09 | 30.82 |
| 2025-05-08 | 31.98 |
| 2025-05-07 | 31.89 |
| 2025-05-06 | 32.52 |